Market Size of Germany Ophthalmic Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.10 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Germany Ophthalmic Devices Market Analysis
The Germany Ophthalmic Devices market is expected to register a CAGR of 6.1% over the forecast period.
The COVID-19 pandemic had interrupted the healthcare services provided all over the nation. Most of the general medical services that were not urgent were postponed to prevent the further spread of the pandemic. Several ophthalmologic surgeries, which were deemed not urgent, were also postponed. The ophthalmic devices market in Germany faced several restrictions during the COVID-19 pandemic. An article titled "Impact of the SARS-CoV-2 pandemic on ophthalmic care in Germany" published in the journal of Ophthalmologe in July 2021 indicated that during the pandemic period, with the exception of endophthalmitis, almost all ophthalmic procedures, including retinal detachment, perforating eyeball injuries, acute glaucoma, central retinal artery occlusion, anterior ischemic optic neuropathy, penetrating keratoplasty, and amniotic membrane transplantation, among others, were declined. The decrease in ophthalmic patient care in the nation during the COVID-19 pandemic significantly affected the growth of the ophthalmic devices market.
Ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices have gained increasing importance and adoption due to the high prevalence of various ophthalmic diseases such as glaucoma, cataract, retinal detachment, and other vision-related issues across the country. An article titled "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study" published in the journal of Ophthalmologica in May 2021 indicated that in Germany, retinal detachment disease had an incidence rate of 42 per 100,000 people per year for the age group of 35-74 years. The study estimated that the incidence of retinal detachment in Germany at the age of 35-74 years is high in comparison to estimates from neighboring European countries. Such a high prevalence of ophthalmic disorders is expected to boost the market's growth over the forecast period.
Moreover, technological advancements and product approvals in the field have boosted the adoption rate of devices in the nation. In June 2021, Implandata Ophthalmic Products, a digital health company, obtained a CE mark for its EYEMATE-SC biosensor. The device will be used in conjunction with the pioneering EYEMATE system for digitally enabled remote glaucoma monitoring and management. EYEMATE-SC is an improved version of its predecessor.
Thus, due to the aforementioned factors, the market for ophthalmic devices in Germany is anticipated to grow. However, although there have been advancements, the devices are still deemed unsafe and can cause damage if not handled professionally. Hence, such factors may restrain the market's growth over the coming years.
